chr2-73901264-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001615.4(ACTG2):​c.-36-12G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.772 in 1,500,930 control chromosomes in the GnomAD database, including 450,845 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 44594 hom., cov: 33)
Exomes 𝑓: 0.77 ( 406251 hom. )

Consequence

ACTG2
NM_001615.4 intron

Scores

2
Splicing: ADA: 0.00001833
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.08

Publications

12 publications found
Variant links:
Genes affected
ACTG2 (HGNC:145): (actin gamma 2, smooth muscle) Actins are highly conserved proteins that are involved in various types of cell motility and in the maintenance of the cytoskeleton. Three types of actins, alpha, beta and gamma, have been identified in vertebrates. Alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. This gene encodes actin gamma 2; a smooth muscle actin found in enteric tissues. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Based on similarity to peptide cleavage of related actins, the mature protein of this gene is formed by removal of two N-terminal peptides.[provided by RefSeq, Dec 2010]
ACTG2 Gene-Disease associations (from GenCC):
  • visceral myopathy 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial visceral myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • megacystis-microcolon-intestinal hypoperistalsis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 2-73901264-G-C is Benign according to our data. Variant chr2-73901264-G-C is described in ClinVar as Benign. ClinVar VariationId is 1188998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTG2NM_001615.4 linkc.-36-12G>C intron_variant Intron 1 of 8 ENST00000345517.8 NP_001606.1
ACTG2NM_001199893.2 linkc.-36-12G>C intron_variant Intron 1 of 7 NP_001186822.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTG2ENST00000345517.8 linkc.-36-12G>C intron_variant Intron 1 of 8 1 NM_001615.4 ENSP00000295137.3

Frequencies

GnomAD3 genomes
AF:
0.762
AC:
115894
AN:
152058
Hom.:
44551
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.701
Gnomad AMI
AF:
0.749
Gnomad AMR
AF:
0.825
Gnomad ASJ
AF:
0.806
Gnomad EAS
AF:
0.569
Gnomad SAS
AF:
0.658
Gnomad FIN
AF:
0.852
Gnomad MID
AF:
0.782
Gnomad NFE
AF:
0.791
Gnomad OTH
AF:
0.777
GnomAD2 exomes
AF:
0.762
AC:
134011
AN:
175786
AF XY:
0.758
show subpopulations
Gnomad AFR exome
AF:
0.694
Gnomad AMR exome
AF:
0.882
Gnomad ASJ exome
AF:
0.806
Gnomad EAS exome
AF:
0.552
Gnomad FIN exome
AF:
0.850
Gnomad NFE exome
AF:
0.782
Gnomad OTH exome
AF:
0.778
GnomAD4 exome
AF:
0.773
AC:
1043134
AN:
1348754
Hom.:
406251
Cov.:
31
AF XY:
0.771
AC XY:
509896
AN XY:
661494
show subpopulations
African (AFR)
AF:
0.701
AC:
20694
AN:
29506
American (AMR)
AF:
0.875
AC:
27452
AN:
31360
Ashkenazi Jewish (ASJ)
AF:
0.813
AC:
16803
AN:
20656
East Asian (EAS)
AF:
0.509
AC:
18234
AN:
35822
South Asian (SAS)
AF:
0.653
AC:
46621
AN:
71446
European-Finnish (FIN)
AF:
0.843
AC:
41699
AN:
49464
Middle Eastern (MID)
AF:
0.758
AC:
4048
AN:
5340
European-Non Finnish (NFE)
AF:
0.786
AC:
825083
AN:
1049802
Other (OTH)
AF:
0.768
AC:
42500
AN:
55358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
10143
20286
30430
40573
50716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20220
40440
60660
80880
101100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.762
AC:
115996
AN:
152176
Hom.:
44594
Cov.:
33
AF XY:
0.762
AC XY:
56730
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.701
AC:
29110
AN:
41502
American (AMR)
AF:
0.826
AC:
12625
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.806
AC:
2799
AN:
3472
East Asian (EAS)
AF:
0.569
AC:
2943
AN:
5174
South Asian (SAS)
AF:
0.658
AC:
3175
AN:
4822
European-Finnish (FIN)
AF:
0.852
AC:
9023
AN:
10592
Middle Eastern (MID)
AF:
0.772
AC:
227
AN:
294
European-Non Finnish (NFE)
AF:
0.791
AC:
53764
AN:
68000
Other (OTH)
AF:
0.778
AC:
1647
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1448
2896
4345
5793
7241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.760
Hom.:
5123
Bravo
AF:
0.761
Asia WGS
AF:
0.661
AC:
2302
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Visceral myopathy 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.9
DANN
Benign
0.51
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000018
dbscSNV1_RF
Benign
0.028
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1721241; hg19: chr2-74128391; COSMIC: COSV61828474; API